UKHCDO confirmed recombinant Factor 8 as the safest product available for the treatment of people with bleeding disorders. Linked evidence BART0000875 - Guidelines on therapeutic products to treat haemophilia and other hereditary coagulation disorders - 03 Oct 1996 Chronology Information Date: 1 October 1996 Chapter/issue Access to Treatment